ImmunoPrecise Antibodies (IPA) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts IPA Hot Sheet
Join SI Premium – FREE
ImmunoPrecise Antibodies (NASDAQ: IPA) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $6.98 million.
For earnings history and earnings-related data on ImmunoPrecise Antibodies (IPA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
- Rothschild Redburn Starts Minimax Group Inc (100:HK) at Buy
- Texas Capital Securities Downgrades Universal Technical Institute (UTI) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
